Impact Factor
3.70
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.34
580 total citations
h5-index
36
h5 depth signal
Cited share
77.5%
107 of 138
Total citations
580
Citation footprint
Metric signal
4.22
External metric anchor
Self-citation
1.4%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
405
United Kingdom
81
Italy
56
Canada
36
Turkey
34
Citing Fields of Research
Musculoskeletal Disorders
505
Auto-Inflammatory Disorders
265
Immunology
142
Osteopathies
51
Inflammatory Bowel Diseases & Infections
31
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,795
Articles tracked across the journal lifetime
Indexed publication set
138
107 cited publications
Last 12 months
63
5.3 publications/month
Open access share
17.5%
11 OA publications in the last year
Leading citing country
United States
405 citing publications
Leading citing field
Musculoskeletal Disorders
505 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Jun. 1989-
v1n1,Jun. 1989-
Active Coverage
Research Focus & Classification
Indexed Subjects
Musculoskeletal Disorders
Auto-Inflammatory Disorders
Broad Categories
Rheumatology
Musculoskeletal Disorders
MeSH Descriptors
Arthritis
Rheumatic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/bor.0000000000001204
Open DOI
Systemic sclerosis in 2026: emerging paradigms from the World Scleroderma Congress
Purpose of review: To summarize recent advances in systemic sclerosis (SSc) highlighted at the 2026 World Scleroderma Congress, focusing on early disease, immunovascular mechanisms, and emerging therapeutic strategies. Recent findings: R...
02
DOI 10.1097/bor.0000000000001208
Open DOI
Genetics of vasculitis
Purpose of review: Systemic vasculitis arises on a background of genetic predisposition shaped by HLA and non-HLA variations, triggered by environmental factors. This review summarizes recent genomic information translating molecular dis...
03
DOI 10.1097/bor.0000000000001193
Open DOI
Rheumatological manifestations of Lyme disease and related tick-borne diseases in north America
Purpose of review: Lyme disease is the most common vector-borne infection in North America, and the incidence continues to rise as the geographic range of Ixodes ticks expands. While most patients can be cured with early antibiotic thera...
04
DOI 10.1097/bor.0000000000001191
Open DOI
The eye in systemic vasculitis
Purpose of review: This review summarizes the spectrum of ocular manifestations in systemic vasculitis, emphasizing recent advances in clinical recognition, multimodal imaging, biomarkers, and targeted treatment. Recent findings: Ocular ...
05
DOI 10.1097/bor.0000000000001185
Open DOI
Clinical application of genomic advances in systemic sclerosis
Purpose of review: Systemic sclerosis (SSc) is a clinically heterogeneous chronic immune-mediated inflammatory disease with the highest mortality rate among all rheumatic diseases. Although current SSc clinical and serological classifica...
06
DOI 10.1097/bor.0000000000001203
Open DOI
From immune heterogeneity to targeted therapies in IgG4-related disease
Purpose of review: Recent advances in single-cell, spatial, and multiomic technologies have provided new insights into the immunopathogenesis and clinical heterogeneity of IgG4-related disease (IgG4-RD). At the same time, several mechani...
07
DOI 10.1097/bor.0000000000001190
Open DOI
Updates on idiopathic inflammatory myopathies: partnering with patients, making progress
Was not provided for this article.
08
DOI 10.1097/bor.0000000000001199
Open DOI
Editorial introductions
Was not provided for this article.
09
DOI 10.1097/bor.0000000000001195
Open DOI
Myositis autoantibodies: from new specificities to new paradigms
Purpose of review: Myositis-specific autoantibodies have long been used to classify patients into clinically meaningful subsets; however, recent studies show that the field is moving beyond the simple question of which autoantibody is pr...
10
DOI 10.1097/bor.0000000000001192
Open DOI
Colchicine-related effects on gene and protein expression in gout
Purpose of review: Gout is an inflammatory arthritis mediated by monosodium urate deposition in synovial tissue. Colchicine is a common treatment for acute gout flares and prophylaxis, with well established efficacy but an incompletely u...
Bibliographical & Catalog Notes
Title from cover.
Place of publication varies.
Also issued online.
Vol. 1, no. 1 (JUN 1989)19900912 Notice published Printed on acid-free paper